Skip to main content
. 2020 Oct 31;12(11):3217. doi: 10.3390/cancers12113217

Figure 4.

Figure 4

Figure 4

E3 MMAE and MMAF induce cell death in a broad number of cancer cells. (a) Viability of MCF7 breast, Jurkat blood and U-118MG brain cancer and PANC-1, MIA PaCa-2 and BxPC-3 pancreatic cancer cells treated with MMAF-E3 and MMAF-C36. (b) Viability of MCF7 breast, Jurkat blood and A431 skin cancer and PANC-1, MIA PaCa-2 and BxPC-3 pancreatic cancer cells treated with MMAF-E3 and MMAF-C36. (c) Viability of MDA-MB-231 breast and SK-N-AS brain cancer cells treated with MMAE-E3 and MMAE-C36 or with MMAF-E3 and MMAF-C36. The MMAE-C36 and MMAF-C36 data for the pancreatic cancer cells is from [13]. Cells were incubated with increasing concentrations of ApTDCs and viability determined at 144 h.